It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A federal advisory panel said Friday the Food and Drug Administration (FDA) should not approve a third booster dose of Pfizer and BioNTech's COVID-19 vaccine for everyone 16 or older, but indicated they would be open to boosters for older people.
The panel voted overwhelmingly against the recommendation, 16 to 2.
Friday's vote from the FDA's vaccine advisory committee deals a major blow to the Biden administration's plan to administer booster doses beginning Sept. 20.
originally posted by: americanbuffalo1
a reply to: ColoradoTemplar
Well he did say he was losing his patience. Maybe he will suffer an aneurysm due to this wrench in his works.
originally posted by: MiddleInsite
It's interesting that the FDA all of a sudden has credibility, when clearly to many here, it did not.
I always find it funny that with most here, that when you agree with the ruling/finding/decision, well then we can trust it. Otherwise, they are a bunch of government hacks.
I don't see how you can not trust them, and in a split second, you can.
Do you see how ridiculous that is?
So you are saying you trust the FDA and the info they distribute to the public?
a reply to: ColoradoTemplar
originally posted by: MiddleInsite
It's interesting that the FDA all of a sudden has credibility, when clearly to many here, it did not.
I always find it funny that with most here, that when you agree with the ruling/finding/decision, well then we can trust it. Otherwise, they are a bunch of government hacks.
I don't see how you can not trust them, and in a split second, you can.
Do you see how ridiculous that is?
So you are saying you trust the FDA and the info they distribute to the public?
a reply to: ColoradoTemplar
Do you see how ridiculous that is?
originally posted by: ColoradoTemplar
a reply to: Vasa Croe
Voting 16 against the recommendation and only 2 for it............those numbers are pretty far apart.
To be clear, the role of the FDA and advisory panel in this case is to determine whether an additional dose can be used, whereas an expert panel advising the CDC (Advisory Committee on Immunization Practices, ACIP), will convene Wednesday to weigh who should receive vaccine and when, following the FDA's final review. Top health officials last month said this group would likely include health care workers and nursing home residents who were targeted in the earliest phases of the rollout.
originally posted by: MiddleInsite
It's interesting that the FDA all of a sudden has credibility, when clearly to many here, it did not.
I always find it funny that with most here, that when you agree with the ruling/finding/decision, well then we can trust it. Otherwise, they are a bunch of government hacks.
I don't see how you can not trust them, and in a split second, you can.
Do you see how ridiculous that is?
So you are saying you trust the FDA and the info they distribute to the public?
a reply to: ColoradoTemplar
originally posted by: Vasa Croe
Just found it....it was VRBPAC. They didn't allow them to review before approving the vaccine but are allowing them to review the booster?
What a odd thing to do.